# Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma

> **NCT04717999** · NA · UNKNOWN · sponsor: **UWELL Biopharma** · enrollment: 20 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **BIOLOGICAL:** NKG2D CAR-T

## Key facts

- **NCT ID:** NCT04717999
- **Lead sponsor:** UWELL Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04717999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04717999, "Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04717999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*